Molbio Diagnostics IPO Review 2026: Is the Valuation Justified? Posted by Sachin Kumar AIViralHub News Desk on August 12, 2026 Diagnostics Stocks Healthcare IPO Healthcare Tech IPO Review IPO Valuation Molbio Diagnostics IPO Molbio IPO 2026 Recurring Revenue Truenat +
₹882 Crore TB Kit Tender: Why the Government Defends TrueNat Procurement Posted by Sachin Kumar AIViralHub News Desk on August 12, 2026 Government Tender Healthcare Stocks IPO 2026 Medical Technology Molbio Diagnostics NTEP TB Diagnostics TB Kit Tender Truenat +
Molbio Diagnostics IPO 2026: ₹281 Crore Anchor Round Explained Posted by Sachin Kumar AIViralHub News Desk on August 12, 2026 Diagnostics Stocks Healthcare IPO IPO analysis IPO Anchor Investors Molbio Diagnostics IPO Molbio IPO 2026 Temasek Truenat +